BioSpace News Archive

The trial is intended to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients with persistent or long-standing persistent atrial fibrillation

New investors increase total committed capital to $49 million while providing additional expertise in diagnostics and Artificial Intelligence

A third of the new drugs identified as innovative therapies with novel mechanisms of action different from existing therapies

Gracell conquers effective, low cost, and high speed manufacturing of cellular gene therapeutics

Allele Biotechnology and Pharmaceuticals Inc., a San Diego based biotechnology company focused on the development and clinical translation of cutting-edge technologies, has partnered with Addgene, a global nonprofit organization helping scientists share plasmids, to further facilitate academic use of mNeonGreen.

After years of work to transform healthcare, BioIQ’s website, messaging and logo have been refreshed to better reflect the people the company serves, including some 15 million who have been served by the company’s consumer-centric approach.

AgroFresh Solutions, Inc. announced that it will release first quarter 2019 results after the market closes on Tuesday, May 7, 2019.

Evofem Biosciences, Inc. announced the completion of patient enrollment in AMPREVENCE, the Phase 2b clinical trial evaluating its lead product candidate Amphora®, a Multipurpose Vaginal pH Regulator™, for the prevention of chlamydia and gonorrhea in women.

Northpond Ventures’ funds will support commercial menu expansion and completion of FDA clinical trials

New Military Health System PDMP Closes Crucial Information Gap to Improve Safety of Controlled Substances for Military Members and their Families